Glen Stuhring
Family Medicine · Shoreline, WANPI 1275515702
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 319 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Pfizer$806
- Johnson & Johnson$786
- Amgen$556
- Gilead$351
- Lilly USA, LLC$234
- plus $2K from 24 others
What the payments were for
- Food & beverage$6,17698%
- Education$1262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,155 |
| Pfizer | 36 | $806 |
| Johnson & Johnson | 35 | $786 |
| Amgen | 26 | $556 |
| Gilead | 18 | $351 |
| Lilly USA, LLC | 14 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $217 |
| Novartis | 14 | $204 |
| GSK | 11 | $201 |
| Boehringer Ingelheim | 10 | $192 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $183 |
| Novo Nordisk | 10 | $170 |
| Teva Pharmaceuticals USA, Inc. | 12 | $167 |
| Astellas Pharma US Inc | 4 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $154 |
| AbbVie(2 entities) | 6 | $118 |
| Sanofi-aventis U.S. LLC | 5 | $108 |
| Esperion Therapeutics, Inc. | 4 | $85 |
| Kowa Pharmaceuticals America, Inc. | 4 | $78 |
| Antares Pharma, Inc. | 5 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Amarin Pharma, Inc. | 3 | $51 |
| Merck | 3 | $46 |
| Phadia US Inc. | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Shire North American Group Inc | 1 | $25 |
| Lundbeck LLC | 1 | $21 |
| Abbott | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Organon | 2 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,302 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Shoreline
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
- Kent WalkerSumner$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.